HealthStudy Reports Weight Reductions Among Adolescents in Zepbound ResearchBy Naomi CalderNov 16, 2026, 12:35 AM UTC
HealthLilly Reports Higher Week 52 Psoriatic Arthritis Response With Taltz, ZepboundBy Naomi CalderNov 11, 2026, 9:26 PM UTC
HealthLilly, Hims & Hers Agree on Platform Access to Two Weight-Loss DrugsBy Naomi CalderNov 7, 2026, 12:25 AM UTC
BusinessLilly Raises 2026 Revenue Outlook as Mounjaro, Zepbound Sales RiseBy Helena WardOct 29, 2026, 10:17 PM UTC
HealthU.S. Employers Scale Back Some GLP-1 Coverage for 2027By Naomi CalderOct 27, 2026, 10:13 PM UTC